LMR Partners LLP Makes New $2.16 Million Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

LMR Partners LLP acquired a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 101,800 shares of the company's stock, valued at approximately $2,155,000. LMR Partners LLP owned 0.08% of Surgery Partners at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. lifted its holdings in Surgery Partners by 19.5% in the third quarter. Franklin Resources Inc. now owns 21,324 shares of the company's stock valued at $677,000 after acquiring an additional 3,487 shares during the period. JPMorgan Chase & Co. increased its position in Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock worth $6,107,000 after purchasing an additional 5,551 shares in the last quarter. Inspire Investing LLC raised its position in shares of Surgery Partners by 47.5% in the fourth quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock valued at $403,000 after buying an additional 6,131 shares during the last quarter. KBC Group NV lifted its stake in shares of Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after purchasing an additional 1,577 shares during the period. Finally, E. Ohman J or Asset Management AB boosted its stake in Surgery Partners by 40.3% in the 4th quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock worth $26,317,000 after buying an additional 357,023 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Macquarie cut their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. Benchmark reaffirmed a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $34.75.

Insider Buying and Selling

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO David T. Doherty sold 6,733 shares of the business's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the completion of the sale, the chief financial officer now owns 150,868 shares in the company, valued at $3,623,849.36. The trade was a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.30% of the company's stock.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY traded down $0.21 during trading on Monday, reaching $23.74. The stock had a trading volume of 123,048 shares, compared to its average volume of 1,197,736. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97. The firm's 50 day moving average price is $22.55 and its two-hundred day moving average price is $23.15. The stock has a market cap of $3.04 billion, a PE ratio of -49.45, a P/E/G ratio of 19.21 and a beta of 1.96.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. During the same period in the prior year, the company earned $0.10 EPS. Surgery Partners's quarterly revenue was up 8.2% on a year-over-year basis. On average, research analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.